interested to see if the NMR drug discovery program goes down the path of identifying an ALKBH5 inhibitor. aLkBH5 knockdown appears to increase cardiotoxicity the same as an FTO inhibitor.
Or perhaps a non-cytotoxic FTO / ALKBH5 inhibitor for other metabolic disorders?
- Forums
- ASX - By Stock
- [INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
interested to see if the NMR drug discovery program goes down...
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.74 |
Change
-0.055(3.07%) |
Mkt cap ! $297.9M |
Open | High | Low | Value | Volume |
$1.79 | $1.79 | $1.72 | $134.5K | 76.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7627 | $1.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.75 | 600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4001 | 1.730 |
1 | 500 | 1.725 |
2 | 3357 | 1.720 |
1 | 538 | 1.715 |
2 | 1703 | 1.710 |
Price($) | Vol. | No. |
---|---|---|
1.750 | 600 | 1 |
1.755 | 1080 | 1 |
1.760 | 1961 | 2 |
1.765 | 5000 | 1 |
1.770 | 140 | 1 |
Last trade - 14.02pm 17/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.76 |
  |
Change
-0.055 ( 0.66 %) |
|||
Open | High | Low | Volume | ||
$1.76 | $1.77 | $1.72 | 21965 | ||
Last updated 15.03pm 17/06/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online